EA201991493A3 - HUMAN ANTIGEN-BINDING PROTEINS THAT BIND WITH Β-CLOTO, FGF RECEPTORS AND THEIR COMPLEXES - Google Patents

HUMAN ANTIGEN-BINDING PROTEINS THAT BIND WITH Β-CLOTO, FGF RECEPTORS AND THEIR COMPLEXES

Info

Publication number
EA201991493A3
EA201991493A3 EA201991493A EA201991493A EA201991493A3 EA 201991493 A3 EA201991493 A3 EA 201991493A3 EA 201991493 A EA201991493 A EA 201991493A EA 201991493 A EA201991493 A EA 201991493A EA 201991493 A3 EA201991493 A3 EA 201991493A3
Authority
EA
Eurasian Patent Office
Prior art keywords
binding proteins
antigen
fgfr3c
fgfr1c
fgfr2c
Prior art date
Application number
EA201991493A
Other languages
Russian (ru)
Other versions
EA201991493A2 (en
Inventor
Шо-Фэнь Ху
Ян Фольтц
Чэдвик Теренс Кинг
Ян ЛИ
Таруна Арора
Original Assignee
Амген Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амген Инк. filed Critical Амген Инк.
Publication of EA201991493A2 publication Critical patent/EA201991493A2/en
Publication of EA201991493A3 publication Critical patent/EA201991493A3/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение предоставляет композиции и способы, относящиеся к антиген-связывающим белкам, активирующим FGF21-опосредованную передачу сигнала, или производным от этих белков. В различных вариантах воплощения антиген-связывающие белки специфично связываются с (i) -Клото; (ii) FGFR1c, FGFR2c, FGFR3c или FGFR4; или (iii) комплексом, содержащим -Клото и одну из молекул FGFR1c, FGFR2c, FGFR3c и FGFR4. В некоторых вариантах воплощения антиген-связывающие белки индуцируют FGF21-подобный сигналлинг. В некоторых вариантах воплощения антиген-связывающие белки являются полностью принадлежащими человеку, гуманизированными или химерными антителами, связывающими фрагментами и производными таких антител, и полипептидами, которые специфично связываются с (i) -Клото; (ii) FGFR1c, FGFR2c, FGFR3c или FGFR4; или (iii) комплексом, содержащим -Клото и одну из молекул FGFR1c, FGFR2c, FGFR3c и FGFR4. В других вариантах воплощения предложены нуклеиновые кислоты, кодирующие такие антиген-связывающие белки и их фрагменты, а также производные и полипептиды, клетки, содержащие такие полинуклеотиды, способы получения таких антиген-связывающих белков, их фрагментов и производных, и полипептидов, и способы применения таких антиген-связывающих белков, их фрагментов и производных, и полипептидов, включая способы лечения или диагностики у субъектов, страдающих диабетом 2 типа, ожирением, НАСГ, метаболическим синдромом и родственными нарушениями или состояниями.The invention provides compositions and methods related to antigen-binding proteins, activating FGF21-mediated signaling, or derived from these proteins. In various embodiments, antigen binding proteins specifically bind to (i) -Cloto; (ii) FGFR1c, FGFR2c, FGFR3c, or FGFR4; or (iii) a complex containing α-Klotho and one of the FGFR1c, FGFR2c, FGFR3c, and FGFR4 molecules. In some embodiments, antigen binding proteins induce FGF21-like signaling. In some embodiments, the antigen binding proteins are wholly human, humanized or chimeric antibodies, binding fragments and derivatives of such antibodies, and polypeptides that specifically bind to (i) -Clotho; (ii) FGFR1c, FGFR2c, FGFR3c, or FGFR4; or (iii) a complex containing α-Klotho and one of the FGFR1c, FGFR2c, FGFR3c, and FGFR4 molecules. In other embodiments, there are provided nucleic acids encoding such antigen-binding proteins and fragments thereof, as well as derivatives and polypeptides, cells containing such polynucleotides, methods for producing such antigen-binding proteins, fragments and derivatives thereof, and polypeptides, and methods of using such antigen-binding proteins, fragments and derivatives thereof, and polypeptides, including methods of treatment or diagnosis in subjects suffering from type 2 diabetes, obesity, NASH, metabolic syndrome, and related disorders or conditions.

EA201991493A 2010-09-10 2010-12-03 HUMAN ANTIGEN-BINDING PROTEINS THAT BIND WITH Β-CLOTO, FGF RECEPTORS AND THEIR COMPLEXES EA201991493A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38184610P 2010-09-10 2010-09-10

Publications (2)

Publication Number Publication Date
EA201991493A2 EA201991493A2 (en) 2020-11-30
EA201991493A3 true EA201991493A3 (en) 2020-12-30

Family

ID=73649882

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991493A EA201991493A3 (en) 2010-09-10 2010-12-03 HUMAN ANTIGEN-BINDING PROTEINS THAT BIND WITH Β-CLOTO, FGF RECEPTORS AND THEIR COMPLEXES

Country Status (1)

Country Link
EA (1) EA201991493A3 (en)

Also Published As

Publication number Publication date
EA201991493A2 (en) 2020-11-30

Similar Documents

Publication Publication Date Title
EA201270634A1 (en) HUMAN ANTIGENS-BINDING PROTEINS CONNECTING β-CLOTHO, FGF RECEPTORS AND THEIR COMPLEXES
WO2012170438A3 (en) HUMAN ANTIGEN BINDING PROTEINS THAT BIND TO A COMPLEX COMPRISING β-KLOTHO AND AN FGF RECEPTOR
EP3670534A3 (en) Human fgf receptor and beta-klotho binding proteins
EA200901436A1 (en) Antigen-binding proteins that bind PAR-2
EA201290570A1 (en) CONSTRUCTIONS CONNECTING WITH RON AND METHODS OF THEIR USE
EA201391761A1 (en) ANTI-ALPHA-SINUCLAIN-BINDING MOLECULES
MX2009003093A (en) Compositions and methods relating to glucagon receptor antibodies.
EA201100923A1 (en) HUMAN ANTIBODIES AGAINST THE TISSUE FACTOR
EA201000238A1 (en) ANTIGEN-BINDING PROTEINS FOR IL-18 RECEPTOR AND THEIR APPLICATION
EA200801621A1 (en) ANTIBODIES DIRECTED ON HER-3 AND THEIR APPLICATION
MX2018008680A (en) Tdp-43 specific binding molecules.
EA201591091A1 (en) Antigen-binding proteins for BCMA
EA201200548A1 (en) Bispecific binding molecules for antiangiogenesis therapy
EA201290849A1 (en) OPTIMIZED MONOCLONAL ANTIBODIES AGAINST THE TISSUE FACTOR INHIBITOR (TFPI)
EA201790438A1 (en) ANTIGEN-BINDING PROTEINS THAT CONNECT WITH CXCR5
CY1120803T1 (en) ANTIGONE BINDING PROTEINS SPECIFIC FOR THE STRUCTURE OF STARCH
EA201991493A3 (en) HUMAN ANTIGEN-BINDING PROTEINS THAT BIND WITH Β-CLOTO, FGF RECEPTORS AND THEIR COMPLEXES
AR118006A2 (en) BINDING PROTEINS TO HUMAN ANTIGENS BINDING b-KLOTHO, FGF RECEPTORS AND COMPLEXES THEREOF
JO3379B1 (en) Human antigen binding proteins that bind b-klotho, fgf receptors and complexes thereof
TH147119A (en) Binding proteins to human antigens (beta) - Klotho, FGF receptors and their complexes.
EA202190387A1 (en) ANTIBODY TO HUMAN CD38 AND ITS USE